Legal & General Group Plc - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$69,115,831
-6.9%
2,546,638
+5.5%
0.02%0.0%
Q2 2023$74,225,590
-8.6%
2,414,630
+7.2%
0.02%
-17.2%
Q1 2023$81,189,931
-8.2%
2,253,400
+0.6%
0.03%
-14.7%
Q4 2022$88,482,698
-3.3%
2,238,936
-1.7%
0.03%
-5.6%
Q3 2022$91,514,000
-2.5%
2,277,597
+2.0%
0.04%
+9.1%
Q2 2022$93,888,000
+13.4%
2,233,295
+5.1%
0.03%
+32.0%
Q1 2022$82,784,000
+12.7%
2,124,840
+15.3%
0.02%
+13.6%
Q4 2021$73,425,000
+35.9%
1,842,516
+23.2%
0.02%
+22.2%
Q3 2021$54,031,000
-10.4%
1,495,030
+1.6%
0.02%
-10.0%
Q2 2021$60,306,000
-1.4%
1,471,237
+4.9%
0.02%
-13.0%
Q1 2021$61,180,000
+158.1%
1,402,572
+196.2%
0.02%
+155.6%
Q4 2020$23,702,000
+2039.2%
473,579
+1698.4%
0.01%
Q3 2020$1,108,000
-65.6%
26,333
-60.3%
0.00%
-100.0%
Q2 2020$3,219,00066,3520.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders